TABLE 1.
Clinical parameter in women with PCOS and control groups.
| Parameters | PCOS (47) | Control (55) | p-value |
| Age at surgery (years) | 29.4 ± 3.9 | 30.0 ± 3.5 | ns |
| BMI (kg/m2) | 23.4 ± 3.1 | 21.7 ± 3.7 | ns |
| Menstrual cycle (days) | 60.2 ± 40.9 | 29.5 ± 2.2 | <0.01 |
| FSH (mIU/ml) | 5.6 ± 1.9 | 6.6 ± 1.8 | <0.01 |
| LH(mIU/ml) | 9.6 ± 6.5 | 4.0 ± 2.0 | <0.01 |
| LH/FSH | 1.6 ± 1.1 | 0.6 ± 0.4 | <0.01 |
| Estradiol (pmol/L) | 230.6 ± 89.8 | 166.6 ± 89.7 | <0.01 |
| Progesterone (nmol/L) | 3.0 ± 3.7 | 1.2 ± 0.4 | ns |
| Testosterone (nmol/L) | 1.3 ± 1.0 | 0.7 ± 0.2 | <0.01 |
| Androstenedione (nmol/L) | 11.1 ± 4.4 | 6.6 ± 3.5 | <0.01 |
| Fasting Glucose (mmol/L) | 4.9 ± 0.5 | 5.2 ± 0.4 | ns |
| Fasting Insulin (mU/L) | 13.5 ± 10.0 | — | — |
| HOMA-IR | 3.0 ± 2.2 | — | — |
| Total cholesterol (mmol/L) | 4.8 ± 0.87 | 4.2 ± 0.92 | <0.01 |
| Triglyceride (mmol/L) | 1.5 ± 1.0 | 0.9 ± 0.5 | <0.01 |
| HDL-C (mmol/L) | 1.3 ± 0.2 | 1.4 ± 0.3 | 0.05 |
| LDL-C (mmol/L) | 3.1 ± 0.8 | 2.6 ± 0.6 | <0.01 |
p-values > 0.05 were considered non-significant (ns). LH, luteinizing hormone; FSH, follicle-stimulating hormone; LDL, low-density lipoprotein; HDL, high-density lipoprotein.